Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells.
Ontology highlight
ABSTRACT: Gene transfer vectors derived from gamma-retroviruses or lentiviruses are currently used for the gene therapy of genetic or acquired diseases. Retroviral vectors display a non-random integration pattern in the human genome, targeting either regulatory regions (gamma-retroviruses) or the transcribed portion of expressed genes (lentiviruses), and have the potential to deregulate gene expression at the transcriptional or post-transcriptional level. A recently developed alternative vector system derives from the avian sarcoma-leukosis alpha-retrovirus (ASLV) and shows favorable safety features compared to both gamma-retroviral and lentiviral vectors in preclinical models. We performed a high-throughput analysis of the integration pattern of self-inactivating (SIN) alpha-retroviral vectors in h
SUBMITTER: Moiani A
PROVIDER: S-EPMC4094940 | biostudies-literature | 2014 May
REPOSITORIES: biostudies-literature
ACCESS DATA